RT Journal Article
SR Electronic
T1 An Antiviral NK-Cell Response Impairs Glioblastoma Virotherapy
JF Cancer Discovery
JO CANCER DISCOVERY
FD American Association for Cancer Research
SP OF19
OP OF19
DO 10.1158/2159-8290.CD-RW2012-219
VO 3
IS 1
YR 2013
UL http://cancerdiscovery.aacrjournals.org/content/3/1/OF19.abstract
AB An NK-cell–mediated immune response reduces the efficacy of oncolytic HSV glioblastoma therapy.